3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Menstruation Disturbances
1
Leiomyoma
1
Endometriosis
1
Endometrial Neoplasms
1
Adenomyosis
1
Interventions
Paclitaxel
35
Bevacizumab
31
Carboplatin
29
pembrolizumab
25
Specimen Handling
20
Magnetic Resonance Spectroscopy
18
olaparib
16
Cisplatin
15
liposomal doxorubicin
13
Taxes
12
Immunoglobulin G
11
Gemcitabine
11
Disulfides
11
Topotecan
9
Nivolumab
9
Cyclophosphamide
9
Biopsy
8
fludarabine
7
Doxorubicin
7
mirvetuximab soravtansine
6
niraparib
5
Radiation
5
Oxaliplatin
5
Fulvestrant
5
Fluorouracil
5
trastuzumab deruxtecan
4
durvalumab
4
cediranib
4
Platinum
4
Megestrol Acetate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Robotic Surgical Procedures
×
Gynecologic
×
30 days
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled